GT200200154A - Nuevos compuestos - Google Patents

Nuevos compuestos

Info

Publication number
GT200200154A
GT200200154A GT200200154A GT200200154A GT200200154A GT 200200154 A GT200200154 A GT 200200154A GT 200200154 A GT200200154 A GT 200200154A GT 200200154 A GT200200154 A GT 200200154A GT 200200154 A GT200200154 A GT 200200154A
Authority
GT
Guatemala
Prior art keywords
new compounds
compounds
present
pulmon
cervical
Prior art date
Application number
GT200200154A
Other languages
English (en)
Inventor
Toshihiko Fujii
Takehiro Okada
Mikio Taniguchi
Fumio Watanabe
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of GT200200154A publication Critical patent/GT200200154A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/08—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon radicals, substituted by hetero atoms, attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0205—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)3-C(=0)-, e.g. statine or derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A NUEVOS COMPUESTOS DE FORMULA GENERAL (I) EN DONDE R1,R2,R3,R4,R5,N, SON GRUPOS FUNCIONALES DESCRITOS EN EL EXPEDIENTE. ESTOS COMPUESTOS PRESENTAN ACTIVIDAD ANTI TUMORAL AL INHIBIR EL CRECIMIENTO DE CELULAS CANCEROSAS POR LO QUE ES DE UTILIDAD EN CANCER COLORECTAL, DE PULMON, DE MAMA, DE ESTOMAGO, CERVICAL.
GT200200154A 2001-07-19 2002-07-18 Nuevos compuestos GT200200154A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01117410 2001-07-19

Publications (1)

Publication Number Publication Date
GT200200154A true GT200200154A (es) 2003-05-16

Family

ID=8178073

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200200154A GT200200154A (es) 2001-07-19 2002-07-18 Nuevos compuestos

Country Status (30)

Country Link
US (1) US6737409B2 (es)
EP (1) EP1412328B1 (es)
JP (1) JP2004534859A (es)
KR (2) KR100611540B1 (es)
CN (1) CN1553897A (es)
AR (1) AR036175A1 (es)
AT (1) ATE341537T1 (es)
BR (1) BR0211289A (es)
CA (1) CA2453987A1 (es)
CO (1) CO5550462A2 (es)
DE (1) DE60215179T2 (es)
DK (1) DK1412328T3 (es)
ES (1) ES2272763T3 (es)
GT (1) GT200200154A (es)
HR (1) HRP20040043A2 (es)
HU (1) HUP0401253A2 (es)
IL (1) IL159890A0 (es)
MX (1) MXPA04000577A (es)
MY (1) MY127718A (es)
NO (1) NO20040198L (es)
NZ (1) NZ530655A (es)
PA (1) PA8551001A1 (es)
PE (1) PE20030258A1 (es)
PL (1) PL367682A1 (es)
PT (1) PT1412328E (es)
RU (1) RU2296750C2 (es)
SI (1) SI1412328T1 (es)
UY (1) UY27388A1 (es)
WO (1) WO2003008378A1 (es)
ZA (1) ZA200400334B (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7256257B2 (en) 2001-04-30 2007-08-14 Seattle Genetics, Inc. Pentapeptide compounds and uses related thereto
NZ555951A (en) * 2002-03-22 2009-01-31 Eisai Co Ltd Hemiasterlin derivatives and uses thereof
US7064211B2 (en) 2002-03-22 2006-06-20 Eisai Co., Ltd. Hemiasterlin derivatives and uses thereof
ES2556641T3 (es) 2002-07-31 2016-01-19 Seattle Genetics, Inc. Conjugados de fármacos y su uso para tratar cáncer, una enfermedad autoinmune o una enfermedad infecciosa
SG195524A1 (en) 2003-11-06 2013-12-30 Seattle Genetics Inc Monomethylvaline compounds capable of conjugation to ligands
WO2005118525A1 (en) * 2004-06-02 2005-12-15 F.Hoffmann-La Roche Ag Synthesis of amino-alkoxy-heptanoic alkyl ester
JP2008519863A (ja) 2004-11-12 2008-06-12 シアトル ジェネティクス インコーポレイティッド Ｎ末端にアミノ安息香酸単位を有するオーリスタチン
RU2007126358A (ru) * 2004-12-13 2009-01-20 Ф.Хоффманн-Ля Рош Аг (Ch) Новая фармацевтическая композиция, содержащая по меньшей мере одно производное доластатина 10
EP1828117A1 (en) * 2004-12-13 2007-09-05 F. Hoffmann-Roche AG Novel process for the manufacture of 3-pyrrolidin-2-yl-propionic acid derivatives
US20060189893A1 (en) * 2005-01-06 2006-08-24 Diamics, Inc. Systems and methods for detecting abnormal cells
US20060161076A1 (en) * 2005-01-06 2006-07-20 Diamics, Inc. Systems and methods for collection of cell clusters
AU2006205909A1 (en) * 2005-01-13 2006-07-20 F. Hoffmann-La Roche Ag New one-step synthesis of useful disubstituted amines
US7772177B2 (en) 2005-05-18 2010-08-10 Aegera Therapeutics, Inc. BIR domain binding compounds
US8871720B2 (en) 2005-07-07 2014-10-28 Seattle Genetics, Inc. Monomethylvaline compounds having phenylalanine carboxy modifications at the C-terminus
ES2708763T3 (es) 2005-07-07 2019-04-11 Seattle Genetics Inc Compuestos de monometilvalina que tienen modificaciones de la cadena lateral de fenilalanina en el extremo C
US7750116B1 (en) 2006-02-18 2010-07-06 Seattle Genetics, Inc. Antibody drug conjugate metabolites
NZ572836A (en) 2006-05-16 2011-12-22 Pharmascience Inc Iap bir domain binding compounds
US20080003652A1 (en) * 2006-06-28 2008-01-03 Hans Iding Novel enzymatic process for the manufacture of Boc-Dap-Oh priority to related application(s)
PE20090481A1 (es) 2007-07-16 2009-05-18 Genentech Inc Anticuerpos anti-cd79b e inmunoconjugados humanizados y metodos de uso
RS52305B (en) 2007-07-16 2012-12-31 Genentech Inc. ANTI-CD79B ANTIBODIES AND IMMUNOCONCULATES AND METHODS OF USE
ES2587392T3 (es) 2008-01-31 2016-10-24 Genentech, Inc. Anticuerpos anti-CD79b e inmunoconjugados y métodos de uso
US8609105B2 (en) 2008-03-18 2013-12-17 Seattle Genetics, Inc. Auristatin drug linker conjugates
CN102933231B (zh) 2010-02-10 2015-07-29 伊缪诺金公司 Cd20抗体及其用途
SG182724A1 (en) 2010-02-12 2012-08-30 Pharmascience Inc Iap bir domain binding compounds
EP2579887B1 (de) 2010-06-10 2014-11-12 Seattle Genetics, Inc. Neue auristatin-derivate und ihre verwendung
US8987209B2 (en) 2010-09-29 2015-03-24 Seattle Genetics, Inc. N-carboxyalkyl-auristatin and the use thereof
US9029406B2 (en) 2011-03-16 2015-05-12 Seattle Genetics, Inc N-carboxyalkylauristatins and use thereof
KR102356286B1 (ko) * 2011-05-27 2022-02-08 암브룩스, 인코포레이티드 비-천연 아미노산 연결된 돌라스타틴 유도체를 함유하는 조성물, 이를 수반하는 방법, 및 용도
DK3170821T3 (da) * 2011-05-27 2021-10-11 Ambrx Inc Sammensætninger som indeholder, fremgangsmåder som involverer, og anvendelser af ikke-naturlige aminosyrebundne dolastatinderivater
US9278996B2 (en) 2012-09-20 2016-03-08 Celltrion, Inc. Dolastatin-10 derivative, method of producing the same and anticancer drug composition containing the same
EP3086815B1 (en) 2013-12-27 2022-02-09 Zymeworks Inc. Sulfonamide-containing linkage systems for drug conjugates
EP3262071B8 (en) 2014-09-23 2022-05-18 F. Hoffmann-La Roche AG Method of using anti-cd79b immunoconjugates
CN105949277B (zh) * 2015-05-05 2019-03-01 成都永泰诺科技有限公司 一种抗肿瘤化合物及其用途
WO2017170637A1 (ja) * 2016-03-29 2017-10-05 東レ株式会社 ペプチド誘導体及びその用途
CN109021065B (zh) * 2017-06-08 2021-10-01 复旦大学 一种制备海兔毒素Dolastatin10的方法
JPWO2023033129A1 (es) 2021-09-03 2023-03-09

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6323315B1 (en) 1999-09-10 2001-11-27 Basf Aktiengesellschaft Dolastatin peptides

Also Published As

Publication number Publication date
DE60215179D1 (de) 2006-11-16
WO2003008378A1 (en) 2003-01-30
MY127718A (en) 2006-12-29
AR036175A1 (es) 2004-08-18
KR20060057652A (ko) 2006-05-26
NZ530655A (en) 2006-08-31
DK1412328T3 (da) 2007-02-12
ES2272763T3 (es) 2007-05-01
JP2004534859A (ja) 2004-11-18
KR20040023661A (ko) 2004-03-18
EP1412328A1 (en) 2004-04-28
ZA200400334B (en) 2005-06-29
PE20030258A1 (es) 2003-03-19
NO20040198L (no) 2004-02-19
PT1412328E (pt) 2007-01-31
PA8551001A1 (es) 2003-09-17
DE60215179T2 (de) 2007-10-18
CO5550462A2 (es) 2005-08-31
HRP20040043A2 (en) 2004-08-31
IL159890A0 (en) 2004-06-20
EP1412328B1 (en) 2006-10-04
UY27388A1 (es) 2003-01-31
SI1412328T1 (sl) 2007-02-28
CA2453987A1 (en) 2003-01-30
ATE341537T1 (de) 2006-10-15
US6737409B2 (en) 2004-05-18
RU2296750C2 (ru) 2007-04-10
BR0211289A (pt) 2004-08-03
CN1553897A (zh) 2004-12-08
MXPA04000577A (es) 2004-04-20
KR100611540B1 (ko) 2006-08-10
HUP0401253A2 (hu) 2004-12-28
PL367682A1 (en) 2005-03-07
US20030055002A1 (en) 2003-03-20
RU2004105145A (ru) 2005-07-10

Similar Documents

Publication Publication Date Title
GT200200154A (es) Nuevos compuestos
GT200300292A (es) Derivados de pirimidina para el tratamiento de crecimiento celular anormal
GT200400161A (es) Piridinonas sustituidas
GT200500242A (es) Procesos para la preparaciòn de 2-(2,6-dioxopiperidin-3-il)-1-oxoisoindolinas sustituidas
GT200500286A (es) Analogos de anilino-pirimidina
GT200200043A (es) Nuevos compuestos antiinflamatorios de bencimidazol
GT200200122A (es) Imidazotriazinas
GT200300087A (es) 2-(2,6-diclorofenil)-diarilimidazoles
GT200300289A (es) Derivados de pirrolopirimidina
IL176075A0 (en) Process for fluorocytidine derivatives
HN2002000067A (es) Inhibidores de la rho - quinasa.
TW200722079A (en) Processes for preparing of glucopyranosyl-substituted benzyl-benzene derivatives and intermediates therein
TW200806328A (en) One-part hair dye composition
PE20050689A1 (es) Inhibidores de quinasas
MA29539B1 (fr) Procedes de production de derives phenoliques 4-biphenylylazetidin -2-one
TW200726750A (en) Stilbene derivatives, light-emitting element and light-emitting device
TW200519096A (en) Quinazoline analogs as receptor tyrosine kinase inhibitors
GT200200259A (es) Fungicidas
ATE372343T1 (de) Verfahren zur herstellung von 6-alkoxy-(6h)- dibenz(c,e)(1,2)-oxaphosphorinen
GT200500308A (es) Nonadepsipeptidos acilados ii
ECSP045396A (es) Proceso para preparar derivados de 6-alquiliden penem
BRPI0407793A (pt) tratamento de osteólise excessiva com compostos de indolinona
GT200300286A (es) Derivados biciclicos para el tratamiento del crecimiento celular anormal
BRPI0416678A (pt) pirazolpirimidinas
GT200200245A (es) Procedimientos para la preparacion de derivados biciclicos sustituidos para el tratamiento del crecimientocelularanormal